Caughey G E, Pouliot M, Cleland L G, James M J
Rheumatology Unit, Royal Adelaide Hospital, South Australia.
J Immunol. 1997 Jan 1;158(1):351-8.
Synthesis of TNF-alpha and IL-1beta, by monocytes/macrophages can be partially regulated by the eicosanoid, PGE2. We report here that inhibition of both PGE2 and thromboxane A2 (TXA2) synthesis by a prostaglandin H synthase inhibitor, NS-398, had no effect on the synthesis of either TNF-alpha or IL-1beta, even though the addition of PGE2 to these treated cells dose-dependently inhibited TNF-alpha and IL-1beta synthesis. Because TXA2 is a major eicosanoid product of stimulated human monocytes, we examined its influence on cytokine production. Inhibition of thromboxane synthase by carboxyheptyl imidazole (CI) resulted in inhibition of TNF-alpha (61 +/- 4.3%; n = 8; p < 0.001) and IL-1beta (54 +/- 4.2%; n = 8; p < 0.001) synthesis by serum-treated zymosan-stimulated nonadherent human monocytes. This effect was observed when cytokine production was measured by ELISA or bioactivity assays. Furthermore, the addition of a TXA2 agonist, carbocyclic TXA2, to CI-treated monocytes dose-dependently restored the levels of TNF-alpha and IL-1beta synthesis to those found with serum-treated zymosan stimulation alone. Inhibition of TXA2 activity by the thromboxane receptor antagonists, pinane TXA2 or SQ 29,548, also inhibited the production of TNF-alpha (67 +/- 2.4% and 65 +/- 2.7%, respectively; n = 8; p < 0.001) and IL-1beta (59 +/- 3.3% and 70 +/- 1.2%, respectively; n = 8; p < 0.001). Treatment with CI resulted in a partial decrease in TNF-alpha mRNA levels (60 +/- 12.0%; n = 4), but had little or no effect on IL-1beta mRNA levels. These novel observations implicate TXA2 as an important paracrine or autocrine facilitator of TNF-alpha and IL-1beta production in stimulated human monocytes and suggest that levels of TNF-alpha and IL-1beta synthesis are determined in part by the balance between TXA2 and PGE2 production in human monocytes.
单核细胞/巨噬细胞合成肿瘤坏死因子-α(TNF-α)和白细胞介素-1β(IL-1β)可部分受类花生酸PGE2的调节。我们在此报告,前列腺素H合成酶抑制剂NS-398对PGE2和血栓素A2(TXA2)合成的抑制作用,对TNF-α或IL-1β的合成均无影响,尽管向这些处理过的细胞中添加PGE2会剂量依赖性地抑制TNF-α和IL-1β的合成。由于TXA2是受刺激的人单核细胞产生的主要类花生酸产物,我们研究了其对细胞因子产生的影响。羧基庚基咪唑(CI)对血栓素合成酶的抑制作用导致血清处理的酵母聚糖刺激的非贴壁人单核细胞合成TNF-α(61±4.3%;n = 8;p < 0.001)和IL-1β(54±4.2%;n = 8;p < 0.001)受到抑制。当通过ELISA或生物活性测定法测量细胞因子产生时,观察到了这种效应。此外,向CI处理的单核细胞中添加TXA2激动剂环戊烷TXA2,可剂量依赖性地将TNF-α和IL-1β的合成水平恢复到仅用血清处理的酵母聚糖刺激时的水平。血栓素受体拮抗剂蒎烷TXA2或SQ 29,548对TXA2活性的抑制作用,也抑制了TNF-α(分别为67±2.4%和65±2.7%;n = 8;p < 0.001)和IL-1β(分别为59±3.3%和70±1.2%;n = 8;p < 0.001)的产生。CI处理导致TNF-α mRNA水平部分降低(60±12.0%;n = 4),但对IL-1β mRNA水平几乎没有影响。这些新的观察结果表明,TXA2是受刺激的人单核细胞中TNF-α和IL-1β产生的重要旁分泌或自分泌促进因子,并提示TNF-α和IL-1β的合成水平部分由人单核细胞中TXA2和PGE2产生之间的平衡所决定。